The largest database of trusted experimental protocols

Pgl3 control firefly luciferase reporter vector

Manufactured by Promega
Sourced in United States

The PGL3-Control firefly luciferase reporter vector is a plasmid that contains the firefly luciferase gene under the control of a constitutive promoter. It can be used as a control vector in gene expression studies.

Automatically generated - may contain errors

6 protocols using pgl3 control firefly luciferase reporter vector

1

Luciferase Reporter Constructs for miR-21 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The luciferase reporter gene constructs (pGL-E1 and pGL-E2E3) were created by cloning a 55-bp fragment from the 3′-UTR (position 2625–2680 of the HPGD mRNA sequence NM_000860, containing the miR-21 site E1) and a 61-bp fragment from the 3′-UTR (position 2860–2921 of the HPGD mRNA sequence NM_000860, containing the miR-21 targeting sites E2 and E3) into the Xba I site of the pGL3-Control firefly luciferase reporter vector (Promega) as described previously [9 (link)]. The corresponding mutant constructs (pGL-E1m, pGL-E2mE3, pGL-E2E3m and pGL-E2mE3m) were created by replacing the seed regions (positions 2–8) of the miR-21 binding sites with 5′-TTTTTTT-3′. All constructs were verified by sequencing. The reporter constructs and the pRL-TK vector (Promega) were co-transfected using Lipofectamine 2000 (Invitrogen). The luciferase activities were then determined as described previously [26 (link)] using a GloMax 20/20 luminometer (Promega). Experiments were performed in quadruplicate.
+ Open protocol
+ Expand
2

Transfecting miRNA and HMGA1P6/P7 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection of miRNA oligonucleotides, cells were transfected with 50 nmol/ml of miRNA precursors or with a control no-targeting scrambled oligonucleotides (Ambion, Austin, TX) using siPORT neoFX Transfection Agent (Ambion). For the HMGA1P6 expression construct (pCAG-HMGA1P6) and the HMGA1P6 luciferase reporter construct (pGL3-HMGA1P6), the entire sequence of HMGA1P6 gene (ENST00000418454.1) was amplified by using the primers Fw HMGA1P6 5'-tcctctaattgggactccga-3' and Rev HMGA1P6 5'-ttactcagatcccaggcaga-3'. The amplified fragment was cloned into pCAG vector kindly given by Dr. S. Soddu, and into pGL3-Control firefly luciferase reporter vector (Promega), respectively. For the HMGA1P7 construct (pCAG-HMGA1P7) and the HMGA1P7 luciferase reporter construct (pGL3-HMGA1P6), the entire sequence of the HMGA1P7 gene (ENST00000406908.1) was amplified by using the primers Fw HMGA1P7 5'-agccagtcgagctggaggtc-3' and Rev HMGA1P7 5'-ctgcaatgtgtactcagagc-3'. The amplified fragment was cloned as described for the HMGA1P6 constructs. All the generated vectors were confirmed by sequencing. The Renilla luciferase vector (pRL-CMV), for transient transfection efficiency, was purchased from Promega. The 3' UTR region of the HMGA1 gene has been previously described [34 (link)].
+ Open protocol
+ Expand
3

Luciferase Assay for miR-222 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual luciferase reporter assays were performed to test for interactions between miR-222 and its target sequence, as previously described [44 (link)]. In brief, a luciferase reporter gene construct for ABCG2 (pGL-ABCG2) was created by cloning the 3′-UTR of ABCG2 [NM_004827, containing the miRNA-222 binding site (5′-UGUAGCA-3′)] into the Xho I and Not I sites of a pGL-3-Control firefly luciferase reporter vector (Promega, Wisconsin, USA). The corresponding mutant construct (pGL-ABCG2m) was created by replacing the seed regions of the miR-222 binding sites with 5′-ACATCGT-3′. These constructs were then verified by sequencing. Cells were transfected with the reporter constructs using Lipofectamine 2000 (Invitrogen, CA, USA). The pRL-TK vector (Promega, Wisconsin, USA) was co-transfected to serve as an internal control for normalization of the transfection efficiency. Luciferase activity was then determined using a GloMax 20/20 luminometer (Promega, Wisconsin, USA), as previously described [15 (link)].
+ Open protocol
+ Expand
4

Praja2 Regulation by miR-155

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vector encoding for praja2 was purchased from Genecopeia (Rockville, USA), all the deletion mutants and the RM were generated as previously described32 (link). AP2-HA vector was purchased from Genescript Biotech (New Jersey, USA). Myc tagged ubiquitin was previously described32 (link). SMART pool siRNA directed against different segments of praja2 coding sequence was purchased from Dharmacon. The following are the siRNA sequences (Thermo Scientific; LU-006916-00- 10) targeting human praja2:
sequence 1: 5′-GAAGCACCCUAAACCUUGA-3′;
sequence 2: 5′ -AGACUGCUCUGGCCCAUUU-3′;
sequence 3: 5′ -GCAGGAGGGUAUCAGACAA-3′;
sequence 4: 5′ -GUUAGAUUCUGUACCAUUA-3′.
The 3′-UTR region of praja2 gene, including binding site for miR-155, was amplified from HEK293 cells by using the following primers:
3′-UTR-XbaI-Fw CTAGTCTAGAGAGATCAGTGTATCAAAGTAAAT;
3′-UTR-XbaI-Rev CTAGTCTAGAGACTCCTTGACACTAACTGATC.
The amplified fragment was cloned into pGL3-Control firefly luciferase reporter vector (Promega) at the XbaI site. HEK293 cells were co-transfected with the pGCL3- Control firefly luciferase reporter vector with the praja2 3′UTR, the Renilla luciferase reporter plasmid and with the hsa-miR-155. Firefly and Renilla luciferase activities were measured 48 h after transfection with the Glomax luminometer microplate reader. Firefly activity was normalized to Renilla activity to control the transfection efficiency.
+ Open protocol
+ Expand
5

Evaluating miR-138 Regulation of PKM2 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
A dual luciferase reporter assay was performed as previously described to test whether miR-138 directly targets PKM2 [30 (link)]. In brief, the luciferase reporter gene constructs for PKM2 (pGL-PKM2) were generated by cloning the 3’-untranslated region (UTR) of PKM2 [NM_002654.5] containing the miR-138 binding site into the XhoI and NotI sites of a pGL-3-Control firefly luciferase reporter vector (Promega, Wisconsin, USA). The corresponding mutant construct (pGL-PKM2 m) was generated by replacing the seed regions of miR-138. These constructs were then verified by sequencing. The cells were transfected with the reporter constructs using Lipofectamine 2000 (Invitrogen, CA, USA). The pRL-TK vector (Promega, Wisconsin, USA) was also co-transfected and served as an internal control to normalize transfection efficiency. Luciferase activity was then determined using a GloMax 20/20 Luminometer (Promega, Wisconsin, USA).
+ Open protocol
+ Expand
6

Bmi1 Promoter Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A dual luciferase assay was performed as described previously 28 (link). Briefly, the dual luciferase reporter gene construct for Bmi1 (pGL-Bmi1) was created by cloning a 925-bp fragment from the promoter of Bmi1 (NM_005180, containing the C-myc binding site (gagcacgtgac)) into the KpnI and HindIII sites of the pGL3-Control firefly luciferase reporter vector (Promega, Madison, WI, USA). The corresponding mutant constructs (pGL-Bmi1mt) were created by replacing the C-myc binding site in the promoter of Bmi1 with 5'-ctcgagcactg-3'. A plasmid containing C-myc was also constructed by cloning a 1365-bp fragment of C-myc cDNA (NM_002467.4) into the BamHI and XhoI sites of pcDNA3.1. The constructs were then verified by sequencing. The cells were transiently cotransfected with pGL-Bmi1 and pcDNA3-C-myc using Lipofectamine (Life Technologies, Carlsbad, CA, USA). The luciferase activity was measured with a luminometer (Tecan, San Jose, CA, USA), and the activities were normalized based on Renilla activity and the protein concentration (cotansfected with pRL-SV40).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!